Aspirin to be evaluated as possible treatment for COVID-19

At least 2,000 patients are expected to randomly get 150 mg of aspirin daily along with the usual treatment


One of UK’s biggest trials, called Recovery, is evaluating the potential of Aspirin, commonly used as a blood thinner, as a possible treatment for coronavirus.

“Patients infected by the novel coronavirus are at a higher risk of blood clots because of hyper-reactive platelets, the cell fragments that help stop bleeding. Aspirin is an antiplatelet agent and can reduce the risk of clots,” the Recovery trial’s website said on Friday (November 6), reported Reuters.

Related News: COVID vaccine developed completely in India may be ready by February

“There is a clear rationale for believing that it (aspirin) might be beneficial, and it is safe, inexpensive and widely available,” said Peter Horby, co-chief investigator of the trial.


About 2,000 patients will be given 150 mg of aspirin besides the usual treatment daily. They will be compared with about 2,000 patients receiving the standard-of-care on its own, the website showed.

Recovery is also studying other common antibiotics such as azithromycin and Regeneron’s antibody cocktail, which was used to treat U.S. President Donald Trump’s COVID-19 symptoms.
Scientists and pharma companies across the world are in the race to find a vaccine for COVID-19. Hyderabad-based Bharat Biotech on Thursday (November 5) said its potential COVID-19 vaccine, Covaxin, could be launched in February 2021.
AstraZeneca, the British-Swedish firm, has said it is likely to get results on the Phase 3 trials of its vaccine candidate by the year-end.
Hungary has said it will start importing small quantities of Russian made COVID-19 vaccine, Sputnik V, in December for final testing and licensing. Australia’s Prime Minister Scott Morrison on Thursday (November 5) announced the country had agreed to purchase 50 million more doses of two more potential Covid-19 vaccines.potential of Aspirin, commonly used as a blood thinner, as a possible treatment for coronavirus.